Since the worldwide emergence of the COVID-19 outbreak, there have been international concerns about the possible viral evolution into variants with underlying mutations that may contribute to their increased transmissibility, disease severity, risk of death, and their potential escape from the immune response or may even lead to its extinction. Rigorous surveillance has revealed the variants harboring mutations in the spike protein, the main target of neutralizing antibodies generated through vaccination or herd immunity. In this review, we have highlighted major SARS-CoV-2 variants as well as other local strains along with their specific mutations, suspected changes in their characteristics, and their impact on the current pandemic and vaccine efficacy. We have also emphasized the need to develop widely protective interventions to curb further transmission of variants.
GrubaughNDPetroneMEHolmesEC.We shouldn’t worry when a virus mutates during disease outbreaks. Nat Microbiol2020;
5:529–30
2.
KupferschmidtK.Fast-spreading UK virus variant raises alarms. Am Assoc Advance Sci2021;371:9--10
3.
WiseJ.Covid-19: new coronavirus variant is identified in UK.
United Kingdom:
British Medical Journal Publishing Group, 2020
4.
GallowaySEPaulPMacCannellDRJohanssonMABrooksJTMacNeilASlaytonRBTongSSilkBJArmstrongGL.Emergence of SARS-CoV-2 b. 1.1. 7 lineage – United States, December 29, 2020–January 12, 2021. Morbid Mortal Week Rep2021;
70:95
5.
LauringASHodcroftEB.Genetic variants of SARS-CoV-2 – what do they mean?JAMA2021;325:529--31
6.
FiorentiniSMessaliSZaniACaccuriFGiovanettiMCiccozziMCarusoA.First detection of SARS-CoV-2 spike protein N501 mutation in Italy in august, 2020. Lancet Infect Dis2021;S1473-3099(21)00007-4
7.
DaviesNGJarvisCIEdmundsWJJewellNPDiaz-OrdazKKeoghRHGroupCC-W. Increased mortality in community-tested cases of SARS-CoV-2 lineage B. 1.1. 7. Nature2021. doi: 10.1038/s41586-021-03426-1
8.
CallawayE.Rare COVID reactions might hold key to variant-proof vaccines. Nature2021;592:20--21
9.
KupferschmidtK.New mutations raise specter of ‘immune escape. Am Assoc Advance Sci2021;371:329--30
10.
HouYJChibaSHalfmannPEhreCKurodaMDinnonKHLeistSRSchäferANakajimaNTakahashiK.SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo. Science2020;
370:1464–8
KorberBFischerWMGnanakaranSYoonHTheilerJAbfaltererWHengartnerNGiorgiEEBhattacharyaTFoleyB.Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell2020;
182:812–27.e19
13.
VolzEHillVMcCroneJTPriceAJorgensenDO’TooleÁSouthgateJJohnsonRJacksonBNascimentoFF.Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell2021;
184:64–75.e11
14.
MahaseE.Covid-19: what have we learnt about the new variant in the UK?
United Kingdom:
British Medical Journal Publishing Group, 2020
15.
Van OosterhoutCHallNLyHTylerKM.COVID-19 evolution during the pandemic – implications of new SARS-CoV-2 variants on disease control and public health policies.
Milton Park:
Taylor & Francis, 2021
16.
ManivannanMJogalekarMPKavithaMSMaranBAVGangadaranP.A mini-review on the effects of COVID-19 on younger individuals. Exp Biol Med2021;
246:293–7
WangPNair Ms LiuLIketaniSLuoYGuoYWangMYuJZhangBKwongPDAntibody resistance of SARS-CoV-2 variants B. 1.351 and B. 1.1. 7. Nature2021;593:130--35
20.
GreaneyAJLoesANCrawfordKHStarrTNMaloneKDChuHYBloomJD.Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe2021;29:463--476.e6
21.
CallawayE.Fast-spreading COVID variant can elude immune responses. Nature2021;
589:500–1
MunninkBBOSikkemaRSNieuwenhuijseDFMolenaarRJMungerEMolenkampRVan Der SpekATolsmaPRietveldABrouwerM.Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science2021;
371:172–7
MuikAWallischA-KSängerBSwansonKAMühlJChenWCaiHMaurusDSarkarRTüreciÖ.Neutralization of SARS-CoV-2 lineage B. 1.1. 7 pseudovirus by BNT162b2 vaccine–elicited human sera. Science2021;
371:1152–3
34.
WuKWernerAPKochMChoiANarayananEStewart-JonesGBColpittsTBennettHBoyoglu-BarnumSShiW.Serum neutralizing activity elicited by mRNA-1273 vaccine. N Engl J Med2021;384:1468--70
